FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Sacher, T; Andrassy, J; Kalnins, A et al.
Shedding Light on the Elusive Role of Endothelial Cells in Cytomegalovirus DisseminationPLOS PATHOGENS. Bd. 7. H. 11. 2011 S. -
Bauer, S; Schulze-Bergkamen, H; Mayer, F et al.
SHORE: A PHASE I/II STUDY OF RESMINOSTAT, AN ORAL HISTONE DEACETYLASE INHIBITOR (HDACI), IN COMBINATION WITH FOLFIRI AS SECOND-LINE TREATMENT IN K-RAS MUTATED COLORECTAL CANCER (CRC) PATIENTSANNALS OF ONCOLOGY. Bd. 22. 2011 S. v118-v119
Aoqui, C; Chmielewski, S; Eissler, R et al.
Short time of high fat intake increases vascular constriction - possible role of local inflammationJOURNAL OF VASCULAR RESEARCH. Bd. 48. 2011 S. 123-123
Kamprath, K; Romo-Parra, H; Haring, M et al.
Short-Term Adaptation of Conditioned Fear Responses Through Endocannabinoid Signaling in the Central AmygdalaNEUROPSYCHOPHARMACOLOGY. Bd. 36. H. 3. 2011 S. 652-663
Becker, Frank; Roos, Frederik C.; Janssen, Martin et al.
Short-term functional and oncologic outcomes of nephron-sparing surgery for renal tumours >= 7 cmEuropean urology. Bd. 59. H. 6. Amsterdam: Elsevier 2011 S. 931 - 937
Busemann, I; Lipke, C; Schattenberg, A et al.
Shortest exposure time possible with LED curing lightsAMERICAN JOURNAL OF DENTISTRY. Bd. 24. H. 1. 2011 S. 37-44
Grabenwoger, M
Should intentional endovascular stent-graft coverage of the left subclavian artery be preceded by prophylactic revascularisation?Eur J Cardiothorac Surg. 2011 S. 1
Weigang, E; Parker, JATC; Czerny, M et al.
Should intentional endovascular stent-graft coverage of the left subclavian artery be preceded by prophylactic revascularisation?EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. Bd. 40. H. 4. 2011 S. 858-868
Loquai, C
Side effect management of new Targeted TherapeuticsJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 9. 2011 S. 108-108
Dieterich, D; Asselah, T; Guyader, D et al.
SILEN-C3: TREATMENT FOR 12 OR 24 WEEKS WITH BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAiVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTIONHEPATOLOGY. Bd. 54. 2011 S. 378A-378A